LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 ...
Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...
These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...
The companies have yet to disclose how many programs they plan to collaborate on or what indications they will prioritize.
Zacks Investment Research on MSN
Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ
Eli Lilly LLY and Johnson & Johnson JNJ are major U.S. healthcare companies within the pharmaceutical/biotech space. Both ...
Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) dominates the search engine market with a greater than 90% share, powering billions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback